Medical Management of Chronic Rhinosinusitis with Nasal Polyposis - Guideline Learning Activities - Guideline Central

Medical Management of Chronic Rhinosinusitis with Nasal Polyposis

American College of Allergy, Asthma, and ImmunologyAmerican Academy of Allergy, Asthma & Immunology

Publication Date: November 8, 2022

The Medical Management of Chronic Rhinosinusitis with Nasal Polyposis guideline, developed by the American College of Allergy, Asthma, and Immunology and the American Academy of Allergy, Asthma & Immunology, provides evidence-based guidance on the use of intranasal corticosteroids (INCS), biologics for chronic rhinosinusitis with nasal polyposis (CRSwNP), and aspirin therapy after desensitization (ATAD) for AERD.
6
Questions
8
Minutes Est.
120
Possible Points
Unrated
Difficulty
Objectives
  • Understanding treatment approaches for chronic rhinosinusitis with nasal polyposis
  • Recognizing the use of aspirin therapy after desensitization for AERD
Instructions
Answer All QuestionsYou must answer each question to move forward.
Get Instant FeedbackAfter you submit each answer, you'll receive an explanation.
Progress is Saved AutomaticallyYour progress is saved as you go, so you can stop and return to the quiz anytime.
Compare Your ResultsSee how your performance compares with your peers after each answer is submitted.
Earn PointsPoints are awarded for each correct answer.
Members Only FeaturesIf you're a member, you can track your progress and view the quizzes you've completed.
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.